Immediate and Delayed Reactions to Trauma-related Laboratory Research Among Rape Survivors and Controls

Moral implications of laboratory-based experimental trauma analysis are usually not properly studied. Feminine rape survivors (N = 62) and controls (N = 79) listened to an audio recording of a sexual assault and accomplished psychological well being measures and the Reactions to Analysis Participation Questionnaire-Revised within the first session and once more a number of weeks later.
Within the first session, psychological well being signs had been related to stronger emotional reactions and private advantages from participation. Rape survivors additionally reported stronger emotional reactions than controls, but additionally extra private advantages, extra satisfaction, and fewer perceived drawbacks from participation. A number of weeks later, each teams reported diminished posttraumatic stress dysfunction signs and rape survivors’ stories of stronger emotional reactions and better satisfaction with their participation remained vital. Profit-cost ratios point out optimistic responses to participation throughout teams and time. Findings recommend vital advantages to laboratory trauma analysis for contributors.

Worldwide Rickettsia Illness Surveillance: An Instance of Cooperative Analysis to Enhance Laboratory Functionality and Capability for Threat Evaluation of Rickettsial Outbreaks Worldwide

Cooperative analysis that addresses infectious illness surveillance and outbreak investigations depends closely on availability and efficient use of acceptable diagnostic instruments, together with serological and molecular assays, as exemplified by the present COVID-19 pandemic. On this paper, we stress the significance of utilizing these assays to assist collaborative epidemiological research to evaluate danger of rickettsial illness outbreaks amongst worldwide associate international locations.
Workforce improvement, mentorship, and coaching are essential elements in constructing laboratory functionality and capability to evaluate danger of and mitigate rising illness outbreaks. Worldwide partnerships that fund cooperative analysis by means of mentoring and on-the-job coaching are profitable examples for enhancing infectious illness surveillance. Cooperative analysis research between the Naval Medical Analysis Heart’s Rickettsial Ailments Analysis Program (RDRP) and 17 institutes from 9 international locations amongst 5 continents had been performed to deal with the presence of and the danger for endemic rickettsial illnesses.
To determine serological and molecular assays within the collaborative institutes, preliminary coaching and continued materials, and technical assist had been supplied by RDRP. The laboratory strategies used within the analysis research to detect and establish the rickettsial infections included (1) group-specific IgM and IgG serological assays and (2) molecular assays.
Twenty-six cooperative analysis initiatives carried out between 2008 and 2020 enhanced the potential and capability of 17 analysis institutes to estimate danger of rickettsial illnesses. These worldwide collaborative research have led to the popularity and/or affirmation of rickettsial illnesses inside every of the associate international locations. As well as, with the identification of particular pathogen and non-pathogen Rickettsia species, a extra correct danger evaluation may very well be made in surveillance research utilizing environmental samples.
The discoveries from these initiatives bolstered worldwide cooperation benefiting not solely the associate international locations but additionally the scientific group at massive by means of shows (n = 40) at worldwide scientific conferences and peer-reviewed publications (n = 18). The cooperative analysis research performed in a number of worldwide institutes led to the incorporation of latest SOPs and trainings for laboratory procedures; biosafety, biosurety, and biosecurity strategies; efficiency of rickettsia-specific assays; and the identification of identified and unknown rickettsial brokers by means of the introduction of latest serologic and molecular assays that complemented conventional microbiology strategies.
Immediate and Delayed Reactions to Trauma-related Laboratory Research Among Rape Survivors and Controls

Laboratory Preparation of Monochloramine for Environmental Analysis: A Comparability of 4 Generally Used Protocols

Monochloramine (MCA) is commonly used as a secondary disinfectant in ingesting water distribution techniques (DWDS) for controlling the regrowth of microorganisms. Laboratory experiments to check the efficacy of MCA and formation of disinfection byproducts in DWDS all require the preparation of MCA. Completely different protocols for the preparation of MCA have been used within the literature.
On this research, we in contrast 4 printed protocols which can be ceaselessly used to arrange MCA within the environmental analysis group. Our outcomes confirmed that the selection of protocol might end in substantial variations in decay kinetics and disinfection efficacy of the ready MCA. The discrepancies spotlight a direct want for the standardization of MCA preparation protocols for laboratory-scale ingesting water analysis.

Human Laboratory Fashions of Hashish Use: Functions for Medical and Translational Psychiatry Analysis

Hashish is more and more utilized by people with psychological well being diagnoses and sometimes presupposed to deal with anxiousness and varied different psychiatric signs. But assist for utilizing hashish as a psychiatric remedy is at present restricted by a scarcity of proof from rigorous placebo-controlled research. Whereas regulatory hurdles and different boundaries make scientific trials of hashish difficult to conduct, dependancy researchers have a long time of expertise finding out hashish use in human laboratory fashions. These embrace strategies to manage hashish administration, to delineate scientific and mechanistic elements of hashish use, and to guage potential remedy functions for hashish and its constituents.
On this paper, we overview these human laboratory procedures and describe how every may be utilized to check hashish use in sufferers with psychiatric issues. As a result of anxiousness issues are among the many most typical psychiatric sicknesses affecting American adults, and anxiousness reduction can also be essentially the most commonly-reported purpose for medicinal hashish use, we focus notably on making use of human laboratory fashions to check hashish results in people with anxiousness and associated issues. Lastly, we focus on how these strategies may be built-in to check hashish results in different psychiatric situations and information future analysis on this space.

The intestine microbiome of laboratory mice: concerns and finest practices for translational analysis

Simply because the intestine microbiota (GM) is now acknowledged as an integral mediator of environmental influences on human physiology, susceptibility to illness, and response to pharmacological intervention, so too does the GM of laboratory mice have an effect on the phenotype of analysis utilizing mouse fashions. A number of experimental elements have been proven to have an effect on the composition of the GM in analysis mice, in addition to the mannequin phenotype, suggesting that the GM represents a significant element in experimental reproducibility.

Progesterone Receptor Antibody

ABF6107 100 ug
EUR 438

Progesterone Receptor antibody

20R-1934 50 ug
EUR 281
Description: Rabbit polyclonal Progesterone Receptor antibody

Progesterone Receptor antibody

20R-2250 50 ug
EUR 281
Description: Rabbit polyclonal Progesterone Receptor antibody

Progesterone receptor antibody

70R-13656 100 ul
EUR 457
Description: Affinity purified Rabbit polyclonal Progesterone receptor antibody

Progesterone receptor antibody

23053-100ul 100ul
EUR 390

Progesterone Receptor Antibody

49338-100ul 100ul
EUR 333

Progesterone Receptor Antibody

49338-50ul 50ul
EUR 239

Progesterone Receptor antibody (Ser190)

70R-37155 100 ug
EUR 349
Description: Rabbit Polyclonal Progesterone Receptor antibody (Ser190)

Progesterone receptor Antibody (Biotin)

20-abx105801
  • EUR 411.00
  • EUR 1845.00
  • EUR 599.00
  • EUR 182.00
  • EUR 300.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Progesterone receptor Antibody (FITC)

20-abx107219
  • EUR 411.00
  • EUR 1845.00
  • EUR 599.00
  • EUR 182.00
  • EUR 300.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Progesterone Receptor (PGR) Antibody

20-abx126356
  • EUR 411.00
  • EUR 592.00
  • EUR 182.00
  • EUR 314.00
  • 100 ul
  • 200 ul
  • 20 ul
  • 50 ul

Progesterone Receptor (PGR) Antibody

20-abx131387
  • EUR 411.00
  • EUR 133.00
  • EUR 1149.00
  • EUR 565.00
  • EUR 314.00
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Progesterone Receptor (PGR) Antibody

abx117208-100ug 100 ug
EUR 467

Progesterone Receptor (pS190) Antibody

20-abx119535
  • EUR 314.00
  • EUR 98.00
  • EUR 398.00
  • EUR 495.00
  • 100 ug
  • 10 ug
  • 200 ug
  • 300 µg

Progesterone receptor Antibody (HRP)

20-abx108639
  • EUR 411.00
  • EUR 1845.00
  • EUR 599.00
  • EUR 182.00
  • EUR 300.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Progesterone Receptor (PGR) Antibody

20-abx110119
  • EUR 411.00
  • EUR 1845.00
  • EUR 599.00
  • EUR 182.00
  • EUR 300.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Progesterone Receptor(PR484) Antibody

BNC040484-100 100uL
EUR 199
Description: Primary antibody against Progesterone Receptor(PR484), CF405S conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR484) Antibody

BNC040484-500 500uL
EUR 544
Description: Primary antibody against Progesterone Receptor(PR484), CF405S conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR500) Antibody

BNC040500-100 100uL
EUR 199
Description: Primary antibody against Progesterone Receptor(PR500), CF405S conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR500) Antibody

BNC040500-500 500uL
EUR 544
Description: Primary antibody against Progesterone Receptor(PR500), CF405S conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR501) Antibody

BNC040501-100 100uL
EUR 199
Description: Primary antibody against Progesterone Receptor(PR501), CF405S conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR501) Antibody

BNC040501-500 500uL
EUR 544
Description: Primary antibody against Progesterone Receptor(PR501), CF405S conjugate, Concentration: 0.1mg/mL

Progesterone Receptor (PGR) Antibody

20-abx339790
  • EUR 411.00
  • EUR 300.00
  • 100 ul
  • 50 ul

Progesterone Receptor (PGR) Antibody

20-abx339976
  • EUR 411.00
  • EUR 300.00
  • 100 ul
  • 50 ul

Progesterone Receptor (PR) Antibody

abx239773-100ug 100 ug
EUR 481

Progesterone Receptor (PGR) Antibody

20-abx159642
  • EUR 272.00
  • EUR 230.00
  • 100 ug
  • 50 ug

Progesterone Receptor (PGR) Antibody

20-abx174169
  • EUR 815.00
  • EUR 425.00
  • 1 mg
  • 200 ug

Progesterone Receptor (PGR) Antibody

abx217233-100ug 100 ug
EUR 439

Progesterone Receptor (pS345) Antibody

abx217728-100ug 100 ug
EUR 439

Progesterone Receptor (PGR) Antibody

abx330393-100ul 100 ul
EUR 425

Progesterone Receptor (PGR) Antibody

20-abx326788
  • EUR 314.00
  • EUR 244.00
  • 100 ug
  • 50 ug

Progesterone Receptor (PGR) Antibody

20-abx324929
  • EUR 314.00
  • EUR 244.00
  • 100 ug
  • 50 ug

Progesterone Receptor (PGR) Antibody

20-abx325043
  • EUR 314.00
  • EUR 244.00
  • 100 ug
  • 50 ug

Progesterone Receptor(PR484) Antibody

BNC430484-100 100uL
EUR 199
Description: Primary antibody against Progesterone Receptor(PR484), CF543 conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR484) Antibody

BNC430484-500 500uL
EUR 544
Description: Primary antibody against Progesterone Receptor(PR484), CF543 conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR500) Antibody

BNC430500-100 100uL
EUR 199
Description: Primary antibody against Progesterone Receptor(PR500), CF543 conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR500) Antibody

BNC430500-500 500uL
EUR 544
Description: Primary antibody against Progesterone Receptor(PR500), CF543 conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR501) Antibody

BNC430501-100 100uL
EUR 199
Description: Primary antibody against Progesterone Receptor(PR501), CF543 conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR501) Antibody

BNC430501-500 500uL
EUR 544
Description: Primary antibody against Progesterone Receptor(PR501), CF543 conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR484) Antibody

BNCH0484-100 100uL
EUR 199
Description: Primary antibody against Progesterone Receptor(PR484), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR484) Antibody

BNCH0484-500 500uL
EUR 544
Description: Primary antibody against Progesterone Receptor(PR484), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR500) Antibody

BNCH0500-100 100uL
EUR 199
Description: Primary antibody against Progesterone Receptor(PR500), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR500) Antibody

BNCH0500-500 500uL
EUR 544
Description: Primary antibody against Progesterone Receptor(PR500), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR501) Antibody

BNCH0501-100 100uL
EUR 199
Description: Primary antibody against Progesterone Receptor(PR501), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR501) Antibody

BNCH0501-500 500uL
EUR 544
Description: Primary antibody against Progesterone Receptor(PR501), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR484) Antibody

BNC550484-100 100uL
EUR 199
Description: Primary antibody against Progesterone Receptor(PR484), CF555 conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR484) Antibody

BNC550484-500 500uL
EUR 544
Description: Primary antibody against Progesterone Receptor(PR484), CF555 conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR500) Antibody

BNC550500-100 100uL
EUR 199
Description: Primary antibody against Progesterone Receptor(PR500), CF555 conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR500) Antibody

BNC550500-500 500uL
EUR 544
Description: Primary antibody against Progesterone Receptor(PR500), CF555 conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR501) Antibody

BNC550501-100 100uL
EUR 199
Description: Primary antibody against Progesterone Receptor(PR501), CF555 conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR501) Antibody

BNC550501-500 500uL
EUR 544
Description: Primary antibody against Progesterone Receptor(PR501), CF555 conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR484) Antibody

BNC800484-100 100uL
EUR 199
Description: Primary antibody against Progesterone Receptor(PR484), CF680 conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR484) Antibody

BNC800484-500 500uL
EUR 544
Description: Primary antibody against Progesterone Receptor(PR484), CF680 conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR500) Antibody

BNC800500-100 100uL
EUR 199
Description: Primary antibody against Progesterone Receptor(PR500), CF680 conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR500) Antibody

BNC800500-500 500uL
EUR 544
Description: Primary antibody against Progesterone Receptor(PR500), CF680 conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR501) Antibody

BNC800501-100 100uL
EUR 199
Description: Primary antibody against Progesterone Receptor(PR501), CF680 conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR501) Antibody

BNC800501-500 500uL
EUR 544
Description: Primary antibody against Progesterone Receptor(PR501), CF680 conjugate, Concentration: 0.1mg/mL

Progesterone Receptor (PGR) Antibody

20-abx001717
  • EUR 411.00
  • EUR 592.00
  • EUR 182.00
  • EUR 314.00
  • 100 ul
  • 200 ul
  • 20 ul
  • 50 ul

Progesterone Receptor (PGR) Antibody

20-abx102047
  • EUR 439.00
  • EUR 133.00
  • EUR 1233.00
  • EUR 592.00
  • EUR 328.00
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Progesterone Receptor(PR484) Antibody

BNC470484-100 100uL
EUR 199
Description: Primary antibody against Progesterone Receptor(PR484), CF647 conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR484) Antibody

BNC470484-500 500uL
EUR 544
Description: Primary antibody against Progesterone Receptor(PR484), CF647 conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR500) Antibody

BNC470500-100 100uL
EUR 199
Description: Primary antibody against Progesterone Receptor(PR500), CF647 conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR500) Antibody

BNC470500-500 500uL
EUR 544
Description: Primary antibody against Progesterone Receptor(PR500), CF647 conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR501) Antibody

BNC470501-100 100uL
EUR 199
Description: Primary antibody against Progesterone Receptor(PR501), CF647 conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR501) Antibody

BNC470501-500 500uL
EUR 544
Description: Primary antibody against Progesterone Receptor(PR501), CF647 conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR484) Antibody

BNCAP0484-100 100uL
EUR 199
Description: Primary antibody against Progesterone Receptor(PR484), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR484) Antibody

BNCAP0484-500 500uL
EUR 544
Description: Primary antibody against Progesterone Receptor(PR484), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR500) Antibody

BNCAP0500-100 100uL
EUR 199
Description: Primary antibody against Progesterone Receptor(PR500), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR500) Antibody

BNCAP0500-500 500uL
EUR 544
Description: Primary antibody against Progesterone Receptor(PR500), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR501) Antibody

BNCAP0501-100 100uL
EUR 199
Description: Primary antibody against Progesterone Receptor(PR501), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR501) Antibody

BNCAP0501-500 500uL
EUR 544
Description: Primary antibody against Progesterone Receptor(PR501), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR484) Antibody

BNCB0484-100 100uL
EUR 199
Description: Primary antibody against Progesterone Receptor(PR484), Biotin conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR484) Antibody

BNCB0484-500 500uL
EUR 544
Description: Primary antibody against Progesterone Receptor(PR484), Biotin conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR500) Antibody

BNCB0500-100 100uL
EUR 199
Description: Primary antibody against Progesterone Receptor(PR500), Biotin conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR500) Antibody

BNCB0500-500 500uL
EUR 544
Description: Primary antibody against Progesterone Receptor(PR500), Biotin conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR501) Antibody

BNCB0501-100 100uL
EUR 199
Description: Primary antibody against Progesterone Receptor(PR501), Biotin conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR501) Antibody

BNCB0501-500 500uL
EUR 544
Description: Primary antibody against Progesterone Receptor(PR501), Biotin conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR484) Antibody

BNC810484-100 100uL
EUR 199
Description: Primary antibody against Progesterone Receptor(PR484), CF680R conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR484) Antibody

BNC810484-500 500uL
EUR 544
Description: Primary antibody against Progesterone Receptor(PR484), CF680R conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR500) Antibody

BNC810500-100 100uL
EUR 199
Description: Primary antibody against Progesterone Receptor(PR500), CF680R conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR500) Antibody

BNC810500-500 500uL
EUR 544
Description: Primary antibody against Progesterone Receptor(PR500), CF680R conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR501) Antibody

BNC810501-100 100uL
EUR 199
Description: Primary antibody against Progesterone Receptor(PR501), CF680R conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR501) Antibody

BNC810501-500 500uL
EUR 544
Description: Primary antibody against Progesterone Receptor(PR501), CF680R conjugate, Concentration: 0.1mg/mL

Progesterone Receptor (pS190) Antibody

20-abx133275
  • EUR 314.00
  • EUR 467.00
  • EUR 203.00
  • 100 ul
  • 200 ul
  • 30 ul

Progesterone Receptor (PGR) Antibody

20-abx133276
  • EUR 300.00
  • EUR 439.00
  • EUR 189.00
  • 100 ul
  • 200 ul
  • 30 ul

Progesterone Receptor (PGR) Antibody

20-abx141043
  • EUR 356.00
  • EUR 537.00
  • EUR 217.00
  • 100 ul
  • 200 ul
  • 30 ul

Progesterone Receptor (PGR) Antibody

20-abx141002
  • EUR 356.00
  • EUR 537.00
  • EUR 217.00
  • 100 ul
  • 200 ul
  • 30 ul

Progesterone Receptor (pS294) Antibody

20-abx009644
  • EUR 314.00
  • EUR 467.00
  • EUR 203.00
  • 100 ul
  • 200 ul
  • 30 ul

Progesterone Receptor (PR) Antibody

abx011372-100ul 100 ul
EUR 411

Progesterone Receptor (PGR) Antibody

abx011378-100ug 100 ug
EUR 439

Progesterone Receptor (pS400) Antibody

abx011379-100ug 100 ug
EUR 439

Progesterone Receptor (pS294) Antibody

abx011380-100ug 100 ug
EUR 439

Progesterone Receptor (PGR) Antibody

abx011381-100ug 100 ug
EUR 439

Progesterone Receptor (PGR) Antibody

abx011382-100ul 100 ul
EUR 411

Progesterone Receptor (PGR) Antibody

abx025331-100ul 100 ul
EUR 523

Progesterone Receptor (PGR) Antibody

abx025332-400ul 400 ul
EUR 523

Progesterone Receptor (PGR) Antibody

abx025332-80l 80 µl
EUR 286

Progesterone Receptor (PGR) Antibody

abx027179-400ul 400 ul
EUR 523

Progesterone Receptor (PGR) Antibody

abx027179-80l 80 µl
EUR 286

Progesterone Receptor (PGR) Antibody

abx031241-400ul 400 ul
EUR 523

Progesterone Receptor (PGR) Antibody

abx031241-80l 80 µl
EUR 286

Progesterone Receptor (PGR) Antibody

abx030889-400ul 400 ul
EUR 523

Progesterone Receptor (PGR) Antibody

abx030889-80l 80 µl
EUR 286

Progesterone Receptor (PGR) Antibody

abx016048-100ul 100 ul
EUR 411

Progesterone Receptor(PR484) Antibody

BNC700484-100 100uL
EUR 199
Description: Primary antibody against Progesterone Receptor(PR484), CF770 conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR484) Antibody

BNC700484-500 500uL
EUR 544
Description: Primary antibody against Progesterone Receptor(PR484), CF770 conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR500) Antibody

BNC700500-100 100uL
EUR 199
Description: Primary antibody against Progesterone Receptor(PR500), CF770 conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR500) Antibody

BNC700500-500 500uL
EUR 544
Description: Primary antibody against Progesterone Receptor(PR500), CF770 conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR501) Antibody

BNC700501-100 100uL
EUR 199
Description: Primary antibody against Progesterone Receptor(PR501), CF770 conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR501) Antibody

BNC700501-500 500uL
EUR 544
Description: Primary antibody against Progesterone Receptor(PR501), CF770 conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR484) Antibody

BNC880484-100 100uL
EUR 199
Description: Primary antibody against Progesterone Receptor(PR484), CF488A conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR484) Antibody

BNC880484-500 500uL
EUR 544
Description: Primary antibody against Progesterone Receptor(PR484), CF488A conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR500) Antibody

BNC880500-100 100uL
EUR 199
Description: Primary antibody against Progesterone Receptor(PR500), CF488A conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR500) Antibody

BNC880500-500 500uL
EUR 544
Description: Primary antibody against Progesterone Receptor(PR500), CF488A conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR501) Antibody

BNC880501-100 100uL
EUR 199
Description: Primary antibody against Progesterone Receptor(PR501), CF488A conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR501) Antibody

BNC880501-500 500uL
EUR 544
Description: Primary antibody against Progesterone Receptor(PR501), CF488A conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR484) Antibody

BNC940484-100 100uL
EUR 199
Description: Primary antibody against Progesterone Receptor(PR484), CF594 conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR484) Antibody

BNC940484-500 500uL
EUR 544
Description: Primary antibody against Progesterone Receptor(PR484), CF594 conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR500) Antibody

BNC940500-100 100uL
EUR 199
Description: Primary antibody against Progesterone Receptor(PR500), CF594 conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR500) Antibody

BNC940500-500 500uL
EUR 544
Description: Primary antibody against Progesterone Receptor(PR500), CF594 conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR501) Antibody

BNC940501-100 100uL
EUR 199
Description: Primary antibody against Progesterone Receptor(PR501), CF594 conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR501) Antibody

BNC940501-500 500uL
EUR 544
Description: Primary antibody against Progesterone Receptor(PR501), CF594 conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR484) Antibody

BNC610484-100 100uL
EUR 199
Description: Primary antibody against Progesterone Receptor(PR484), CF660R conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR484) Antibody

BNC610484-500 500uL
EUR 544
Description: Primary antibody against Progesterone Receptor(PR484), CF660R conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR500) Antibody

BNC610500-100 100uL
EUR 199
Description: Primary antibody against Progesterone Receptor(PR500), CF660R conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR500) Antibody

BNC610500-500 500uL
EUR 544
Description: Primary antibody against Progesterone Receptor(PR500), CF660R conjugate, Concentration: 0.1mg/mL
Furthermore, a number of current research recommend that manipulation of the GM of laboratory mice can considerably enhance the predictive energy or translatability of information generated in mouse fashions to the human situations beneath investigation. This overview supplies readers with info associated to those varied elements and practices, and suggestions concerning strategies by which points with poor reproducibility or translatability may be reworked into discoveries.

Leave a Reply

Your email address will not be published.